Navigation Links
Statistical tool could explain gene study variations
Date:5/28/2008

While scientists are using the human genome to associate certain genes with disease, Dr. Hongyan Xu wants to ensure they are accounting for natural variations in those genes.

"These differences can create some challenges in analyzing data," says Dr. Xu, biostatistician in the Medical College of Georgia School of Graduate Studies. "There is always some difference in ethnic backgrounds across a study population."

For instance, a study looking at a population of blacks from Augusta and blacks from Chicago wouldn't necessarily take into account the difference in subpopulations, he says.

"Some groups of blacks could have different degrees of ancestry from different African groups," he says. "Some populations of blacks have different skin tones, which indicate a difference in genetic makeup. That isn't always taken into account."

Scientists use genome-wide association studies to compare the genes of people with health conditions to the genes of healthy people, thereby better understanding basic biological processes that affect health and possibly how to better diagnose and treat disease.

Some studies account for differences by using control groups who self-report similar ethnicities. But there can be wide variations because people are not always completely aware of their ancestry, Dr. Xu says.

A computer-based statistical tool could be the answer, he says.

Dr. Xu and colleagues will start by examining an existing database from an ongoing association study of stroke risk in black children. That study, conducted by Dr. Abdullah Kutlar, hematologist/oncologist and director of the MCG Sickle Cell Center, aims to understand the genetics of stroke risk in children with sickle cell disease. With funding from the National Institutes of Health, Dr. Xu and his team will take a closer look at children already identified as high-risk because of high blood flow velocity in the brain, as measured by transcranial Doppler tests.

Previous MCG research identified high-velocity blood flow as a risk factor for stroke and regular blood transfusions as a way to reduce that risk.

"While Dr. Kutlar is looking for the underlying genetic reasons for the higher stroke risks in this sample of patients, we will be looking for ways to identify the subpopulations in that sample," Dr. Xu says. "If population structure isn't taken into account, it could affect the validity of study results."

Researchers will use a statistical approach known as coalescent theory, which traces coding sequences of genes in a population sample to a single ancestral copy of a gene. That gene would theoretically be copied in the genetics of every member of an identical population.

For instance, two people with almost identical sets of chromosomes could differ in a very small way by one structural unit that binds their DNA. By tracing it back, researchers would reach a point where the "copied" gene would not be present. That would indicate the point where two lineages joined, Dr. Xu says.

Genetic differences among the two populations could then be tagged, subcategorized and accounted for in study results, he says.

"With the coalescent theory, we focus on the samples rather than the whole population," Dr. Xu says. "That way, we can generate samples with various levels of population structure with great efficiency using computers, which are important for large-scale genome-wide studies. Understanding the genetic basis for disease is key to prevention, diagnosis and effective treatment. Developing a method that accounts for variations in the genetics of people who are similar but distinct is crucial to better understanding the genetics of health."


'/>"/>

Contact: Jennifer Hilliard
jhilliard@mcg.edu
706-721-8604
Medical College of Georgia
Source:Eurekalert  

Related biology news :

1. Research suggests parts of UK could be too hot for wine making by 2080
2. Research suggests parts of UK could be too hot for wine-making by 2080
3. Fluorescent nano-barcodes could revolutionize diagnostics
4. Molecular clock could predict risk for developing breast cancer
5. Sugar linkage could lead to better treatment for autoimmune diseases
6. Fruit fly avoidance mechanism could lead to new ways to control pain in humans
7. UF scientists discover compound that could lead to new blood pressure drugs
8. New 3-D ultrasound could improve stroke diagnosis, care
9. Inflammation triggers cell fusions that could protect neurons, Stanford research shows
10. Smithsonian scientists find evidence that could rewrite Hawaiis botanical history
11. For some who have lost their sense of smell, a once popular asthma drug could help
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statistical tool could explain gene study variations
(Date:3/20/2017)... , March 20, 2017 PMD Healthcare announces ... spirometer and Wellness Management System (WMS), a remote, real-time ... in 2010, PMD Healthcare is a Medical Device, Digital ... mission dedicated to creating innovative solutions that empower people ... that intent focus, PMD developed the first ever personal ...
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , ... Well Made Simple," and 23andMe , the leading ... better food choices.  Zipongo can now provide customers with ... preferences, health goals and biometrics, but also genetic markers ... choices. Zipongo,s personalized food decision support platform ...
(Date:3/2/2017)... Summary This report provides all the ... interests and activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... report provides an in-depth insight into the partnering activity of ... On demand company reports are prepared upon purchase to ensure ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/22/2017)... 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today ... (RGC), U.K. Biobank and GSK to generate genetic sequence data ... The initiative will enable researchers to gain valuable insights to ... wide range of serious and life threatening diseases. ... Genetic evidence ...
(Date:3/22/2017)... , March 22, 2017 Oramed ... ( www.oramed.com ), a ... oral drug delivery systems, announced today that Dr. ... will deliver a presentation titled, "Oral Insulin for ... Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) ...
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017   ... of next-generation cancer therapeutics designed to target cancer stemness ... Patricia S. Andrews as Chief Executive Officer, ... will succeed Chiang J. Li , M.D., FACP, ... company ten years ago. Under his leadership, Boston Biomedical ...
Breaking Biology Technology: